BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 34530455)

  • 1. Trends in diagnostic and therapeutic strategies for extra-abdominal desmoid-type fibromatosis: Japanese musculoskeletal oncology group questionnaire survey.
    Murase F; Nishida Y; Hamada S; Sakai T; Shimizu K; Ueda T
    Jpn J Clin Oncol; 2021 Nov; 51(11):1615-1621. PubMed ID: 34530455
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extra-abdominal desmoid fibromatosis: A review of management, current guidance and unanswered questions.
    Eastley N; McCulloch T; Esler C; Hennig I; Fairbairn J; Gronchi A; Ashford R
    Eur J Surg Oncol; 2016 Jul; 42(7):1071-83. PubMed ID: 26965303
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical results of active surveillance for extra-abdominal desmoid-type fibromatosis.
    Sakai T; Nishida Y; Ito K; Ikuta K; Urakawa H; Koike H; Imagama S
    Cancer Med; 2023 Mar; 12(5):5245-5254. PubMed ID: 36210645
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is immunohistochemical staining for β-catenin the definitive pathological diagnostic tool for desmoid-type fibromatosis? A multi-institutional study.
    Koike H; Nishida Y; Kohno K; Shimoyama Y; Motoi T; Hamada S; Kawai A; Ogose A; Ozaki T; Kunisada T; Matsumoto Y; Matsunobu T; Ae K; Gokita T; Sakai T; Shimizu K; Ishiguro N
    Hum Pathol; 2019 Feb; 84():155-163. PubMed ID: 30292627
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of beta-catenin mutations in paraffin-embedded sporadic desmoid-type fibromatosis by mutation-specific restriction enzyme digestion (MSRED): an ancillary diagnostic tool.
    Amary MF; Pauwels P; Meulemans E; Roemen GM; Islam L; Idowu B; Bousdras K; Diss TC; O'Donnell P; Flanagan AM
    Am J Surg Pathol; 2007 Sep; 31(9):1299-309. PubMed ID: 17721184
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is mutation analysis of β-catenin useful for the diagnosis of desmoid-type fibromatosis? A systematic review.
    Sakai T; Hamada S; Koike H; Shimizu K; Yoshida M; Nishida Y
    Jpn J Clin Oncol; 2020 Sep; 50(9):1037-1042. PubMed ID: 32533146
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunohistochemical staining with non-phospho β-catenin as a diagnostic and prognostic tool of COX-2 inhibitor therapy for patients with extra-peritoneal desmoid-type fibromatosis.
    Sakai T; Nishida Y; Hamada S; Koike H; Ikuta K; Ota T; Ishiguro N
    Diagn Pathol; 2017 Aug; 12(1):66. PubMed ID: 28851389
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of Tranilast on the Frequency of Invasive Treatment for Extra-Abdominal Desmoid Fibromatosis.
    Fujita S; Takeyama M; Kato S; Kawabata Y; Nezu Y; Hayashida K; Saito K; Kato I; Washimi K; Choe H; Hiruma T; Inaba Y
    J Nippon Med Sch; 2023 Mar; 90(1):79-88. PubMed ID: 36436917
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adipocyte-rich
    Bakker A; Slack JC; Caragea M; Kurek KC; Bründler MA
    Pediatr Dev Pathol; 2021; 24(1):62-67. PubMed ID: 33104413
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Desmoid fibromatosis: is the current picture changing?
    Pandrowala S; Jones RL; Gupta S; Gulia A
    Future Oncol; 2021 Sep; 17(25):3397-3408. PubMed ID: 34227399
    [TBL] [Abstract][Full Text] [Related]  

  • 11. β-catenin (CTNNB1) mutations and clinicopathological features of mesenteric desmoid-type fibromatosis.
    Huss S; Nehles J; Binot E; Wardelmann E; Mittler J; Kleine MA; Künstlinger H; Hartmann W; Hohenberger P; Merkelbach-Bruse S; Buettner R; Schildhaus HU
    Histopathology; 2013 Jan; 62(2):294-304. PubMed ID: 23020601
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tailored Beta-catenin mutational approach in extra-abdominal sporadic desmoid tumor patients without therapeutic intervention.
    van Broekhoven DL; Grünhagenl DJ; van Dalen T; van Coevorden F; Bonenkamp HJ; Been LB; Bemelmans MH; Dijkstra SD; Colombo C; Gronchi A; Verhoef C
    BMC Cancer; 2016 Aug; 16(1):686. PubMed ID: 27565718
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness of doxorubicin-based and liposomal doxorubicin chemotherapies for patients with extra-abdominal desmoid-type fibromatosis: a systematic review.
    Shimizu K; Kawashima H; Kawai A; Yoshida M; Nishida Y
    Jpn J Clin Oncol; 2020 Oct; 50(11):1274-1281. PubMed ID: 32700733
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk factors of local recurrence after surgery in extraabdominal desmoid-type fibromatosis: A multicenter study in Japan.
    Nishida Y; Hamada S; Kawai A; Kunisada T; Ogose A; Matsumoto Y; Ae K; Toguchida J; Ozaki T; Hirakawa A; Motoi T; Sakai T; Kobayashi E; Gokita T; Okamoto T; Matsunobu T; Shimizu K; Koike H
    Cancer Sci; 2020 Aug; 111(8):2935-2942. PubMed ID: 32539220
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radiation-induced Sarcomas Occurring in Desmoid-type Fibromatosis Are Not Always Derived From the Primary Tumor.
    Verschoor AJ; Cleton-Jansen AM; Wijers-Koster P; Coffin CM; Lazar AJ; Nout RA; Rubin BP; Gelderblom H; Bovée JV
    Am J Surg Pathol; 2015 Dec; 39(12):1701-7. PubMed ID: 26414222
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of low-dose chemotherapy with methotrexate and vinblastine for patients with extra-abdominal desmoid-type fibromatosis: a systematic review.
    Shimizu K; Hamada S; Sakai T; Koike H; Yoshida M; Nishida Y
    Jpn J Clin Oncol; 2020 Apr; 50(4):419-424. PubMed ID: 31845730
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multifocal occurrence of extra-abdominal desmoid type fibromatosis - A rare manifestation. A clinicopathological study of 6 sporadic cases and 1 hereditary case.
    Bekers EM; van Broekhoven DLM; van Dalen T; Bonenkamp JJ; van der Geest ICM; de Rooy JWJ; van Gorp JM; Creytens DH; de Leng WWJ; Scheijen B; Eijkelenboom A; Flucke U
    Ann Diagn Pathol; 2018 Aug; 35():38-41. PubMed ID: 29705714
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Desmoid-Type Fibromatosis: Who, When, and How to Treat.
    Martínez Trufero J; Pajares Bernad I; Torres Ramón I; Hernando Cubero J; Pazo Cid R
    Curr Treat Options Oncol; 2017 May; 18(5):29. PubMed ID: 28439797
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinicopathological features of 70 desmoid-type fibromatoses confirmed by β-catenin immunohistochemical staining and CTNNB1 mutation analysis.
    An J; Woo HY; Lee Y; Kim HS; Jeong J; Kim SK
    PLoS One; 2021; 16(4):e0250619. PubMed ID: 33914771
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An unusual finding in a desmoid-type fibromatosis of the pancreas: a case report and review of the literature.
    Torres JC; Xin C
    J Med Case Rep; 2018 May; 12(1):123. PubMed ID: 29751773
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.